EXO-CD24 is under clinical development by Nano24med and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Some foods could help people with COVID-19 recover more quickly and suffer less symptoms by calming an internal storm.

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

Teen's recovery from H5N1 bird flu raises concerns after genetic mutations suggest virus could become more dangerous to ...

INR:0174. canada kabaddi cup 2023 points table 62 pharmaceutical companies announced their annual results; the cold winter of ...

Genetic analysis of H5N1 bird flu virus that infected a Canadian teenager shows 'worrisome' mutations, new studies reveal.

INR:6974. bosta images What exactly is a “cytokine storm”? Why can it suddenly worsen a disease? 130 cases: The National Health Commission published data on asym ...

INR:7716. cricket project file Eli Lilly launches COVID-19 Phase III trial: Olumiant treats cytokine storm! The risk of disease progression or death is reduc ...

azamgarh call girl Incyte initiates Phase III study of JAK inhibitor for COVID-19-associated cytokine storm ASH | Phase 2 data on precision anticancer therapy for rare immune diseases is positive 74 ...

INR:6282. casino ewallet As of 24:00 on April 12: There are 867 confirmed cases and 72 suspected cases imported from abroad I-Mab Develops TJM2 to Treat Cytokine S ...

A Canadian teen fully recovered from H5N1 bird flu, but researchers warn of alarming mutations that enhance the virus's ability to infect humans, posing serious health threats. Learn more in this ...

Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, ...